OnStar expands emergency response and roadside assistance to motorcyclists

General Motors has been putting its OnStar in-vehicle safety and security suite into its vehicles since 1997 with the system having undergone numerous evolutions, upgrades and expansions in the last quarter century. Soon its roadside assistance and crash monitoring services will be available to two-wheeled motorists and homebodies as well, the company announced on Thursday.

As part of a modernizing redesign OnStar is making its Guardian crash monitoring and roadside assistance features available to motorcyclists. The service will rely on the accelerometer and other sensors in the rider’s cellphone to determine if a crash has occurred (rather than using the vehicle’s sensor suite as would happen in an automobile wreck) but otherwise is identical to the existing triage and response process. The roadside assistance will include jump starts, gas deliveries and flatbed tows.

The company is also expanding its Alexa integration, which GM began testing last year with select OnStar subscribers. Like having a red telephone to 911, this service will immediately connect members “to an OnStar Emergency Certified Advisor” through their Alexa-connected device, “in scenarios where Members need to call for help hands-free and time is of the essence.” Today, that Alexa skill is available to every US OnStar subscriber.

250,000 car deliveries in one quarter can’t save Tesla from dwindling revenue

The supply chain issues that have wracked the rest of the automotive industry for more than a year appear to have finally caught up with Tesla. The EV automaker announced on Wednesday’s Q2 investors report that its automotive revenue has declined by more than 13 percent following last quarter’s record-breaking mark despite ending the quarter with “the highest vehicle production month” in company history. 

Per the company, Tesla produced 258,580 vehicles last quarter and delivered 201,304 of them. During last quarter’s investor call, CEO Elon Musk estimated that the company could increase its annual deliveries by 60 percent in 2022. To date, the company has delivered 564,743 vehicles and would need to sell another 935,257 of them by year’s end to meet that goal. 

This could prove challenging given that the company produced nearly 18 percent fewer vehicles this quarter than last (though still up 27 percent year over year). COVID-related lockdowns shuttered the Shanghai Gigafactory for most of Q2, though ramping production at the newer Austin and Berlin-Brandenburg plants have helped offset the closure. Austin has begun producing vehicles with the company’s new 4680 battery cells and the Berlin Gigafactory notched a production rate of more than a thousand vehicles in a single week during the last three months. 

“It is worth emphasizing that we have enough 2170 cells to satisfy all vehicle production or the remainder of the year,” Musk said. Tesla had generally managed to avoid the supply chain woes that have hamstrung the automotive industry since the start of the pandemic — until now. The MSRP of a Model Y long-range currently sits just under $66,000, that’s 30 percent higher than it cost in 2021. Tesla is continuing to focus on “production readiness” for its long delayed Cybertruck, Musk noted during the call, with production starting by “middle of next year.”

The company was sure to point out that its total revenue grew 42 percent year over year to $16.9 billion, operating income had improved year over year to $2.5 billion (with an impressive 14.6 percent operating margin) and is currently sitting atop a $18.9 billion pile of cash.

This is thanks in large part to Tesla’s liquidating 75 percent of its Bitcoin holdings (worth $936 million) over the past three months. The company invested $1.5 billion in the digital pseudo-currency in February 2021 and sold off a 10 percent stake a couple months later. Tesla’s backing of Bitcoin, much as with Musk’s pet Dogecoin currency, helped to further mainstream the crypto schemes. Musk reportedly had “a super bad feeling about the economy” in June. “We have not sold any of our Dogecoin,” Musk said.

Hitting the Books: How mass media transformed coyotes into scapegoats

As the boundaries between developed spaces and wildlands continue to blur, the frequency and intensity of human-animal interactions will surely increase. But it won’t just be adorably viral trash pandas and pizza rats whistling on your veranda — it’ll …

GM is building a ‘coast-to-coast’ EV fast-charging network

Electric vehicle adoption has reached its tipping point in the US. With more and more EVs appearing on American roadways, automakers and charging networks alike are working to build out increasingly critical power infrastructure to keep those EVs movin…

Meta’s ‘Make-A-Scene’ AI blends human and computer imagination into algorithmic art

Text-to-image generation is the hot algorithmic process right now, with OpenAI’s Craiyon (formerly DALL-E mini) and Google’s Imagen AIs unleashing tidal waves of wonderfully weird procedurally generated art synthesized from human and computer imaginati…

Hyundai’s first EV sedan is the futuristic Ioniq 6

While Tesla, Ford and GM all (very publicly) vie for the top spot in the American electric vehicle market, Hyundai has quietly built a powerhouse lineup of EVs that threatens to surpass them all. On Wednesday (Thursday in Korea), Hyundai Motor Group of…

Panasonic is building the world’s largest EV battery factory in Kansas

Panasonic announced on Wednesday that it’s inked a $4 billion investment deal with the state of Kansas to build and operate the world’s largest battery cell production facility. The company has already identified a site near the city of De Soto, at a former ammunition factory.

“As the largest private investment in Kansas history and one of the largest EV battery manufacturing plants of its kind in the country, this project will be transformative for our state’s economy, providing in total 8,000 high-quality jobs that will help more Kansans create better lives for themselves and their children,” Kansas Governor Laura Kelly, a Democrat, said during Wednesday’s press conference.

The plant will produce high-capacity cells for Tesla, according to Nikkei Asia. Panasonic already jointly operates the Reno, Nevada Gigafactory with the automaker. Tesla opened a third Gigafactory, in Austin, this past April. This project is expected to produce 4,000 permanent jobs at the factory as well as 16,500 construction jobs.

Despite the global economic shock and supply chain shortages instigated by the COVID-19 pandemic, Tesla saw its vehicle deliveries jump nearly 90 percent between 2020 and 2021. The company had begun developing a proprietary line of batteries in 2019 and has been routinely snapping up exclusive deals with lithium suppliers.

Similarly, GM and Ford have made sizable investments in both battery and EV production facilities, in recent years. GM is spending $7 billion in Michigan alone, part of which is going towards a $2.4 billion battery and EV facility outside Lansing, while Ford has put up a whopping $29 billion towards its electrification and autonomous technology commitments. 

Tesla’s Director of AI is leaving the company (Updated)

Tesla Director of AI, Andrej Karpathy, is stepping down from his role at the company and from the helm of its Autopilot program. “It’s been a great pleasure to help Tesla towards its goals over the last 5 years and a difficult decision to part ways,” Karpathy announced via Twitter on Wednesday, having just returned from a four-month sabbatical. 

The news follows suspicions, then confirmations, that Tesla would be reducing its workforce by as much as 10 percent. The company has already laid off more than 200 employees from the Autopilot division and permanently shuttered its San Mateo offices. Musk has previously made overtures about packing up and leaving Silicon Valley, where Tesla was founded, for the sun-baked shores of central Texas. The company moved its headquarters from California to Austin last October and has heavily focused its new production capabilities there.  

Before becoming the Senior Director of AI at Tesla, Karpathy was a research scientist with OpenAI’s deep learning program focusing on computer vision and generative modeling. Prior to that, he was part of Fei-Fei Li’s research team at Stanford for his PhD. Karpathy has “no concrete plans” yet for the future but is looking to “spend more time revisiting my long-term passions around technical work in AI, open source and education,” he noted in a subsequent tweet.  

Update (7:30 PM ET 7/13/22): The Information reports that Karpathy is not the only Tesla executive to depart today. A “senior director focused on DEI” has also apparently left, as well as Chris Rollins, a senior software manager in Tesla’s energy division. Kristen Kavanaugh, a senior director focused on diversity and inclusion, resigned last month.

Hitting the Books: Modern social media has made misinformation so, so much worse

It’s not just that one uncle who’s not allowed at Thanksgiving anymore who’s been spreading misinformation online. The practice began long before the rise of social media — governments around the world have been doing it for centuries. But it wasn’t un…

Pressure mounts on FDA to expand pig-to-human organ transplant research

In January, doctors at the University of Maryland School of Medicine made history by successfully transplanting a pig’s heart into a human. The 57-year-old patient may have died two months later due to complications from the experimental procedure, but the case has inspired scientists throughout the medical field to call on the FDA to expand the scope and scale of human-porcine transplantation research. During a two-day conference in late June, policy advisors to the FDA and medical professionals discussed the future of xenotransplantation and “most attendees agreed that human trials are needed to help answer the most pressing research questions,” according to Nature. 

We’ve been stuffing pig organs into sick people since the early 19th century, but the technology has made rapid strides in recent decades thanks in part to the advent of CRISPR technology and more potent immunosuppressives. In 2017, researchers created the first human-pig hybrid embryo as well as devised a solution to potential inter-species viral infections. As of January, 2022, were implanting genetically modified pig kidneys into brain-dead donor recipients with great success.

“Our goal is not to have a one-off, but to advance the field to help our patients,” Dr. Jayme Locke, lead surgeon of the kidney study and director of UAB’s Incompatible Kidney Transplant Program, told the NYT. “What a wonderful day it will be when I can walk into clinic and know I have a kidney for everyone waiting to see me.”

Humans have also conducted numerous experimental pig-organ transplants into primates like baboons. But in order to safely and consistently do it with humans, researchers will have to test the techniques on humans, Caroline Zeiss, a veterinary specialist at Yale School of Medicine, told Nature. For example, doctors found traces of porcine cytomegalovirus (PCMV) in the heart transplant patient who died earlier this year and believe that it may have played a role in his demise, but they won’t know for sure without further tests that a primate model — ones that can’t be replicated in primates.

Researchers are only looking at “small, focused” clinical trials with “appropriately selected patients,” Allan Kirk, a transplant surgeon at the Duke University School of Medicine, told Nature. Researchers will have to answer a number of fundamental questions before the technology can be widely utilized, as well as determine the right mix of breeding and genetic tinkering needed to ensure that recipients’ bodies won’t reject them.

And while the decisions made during last week’s meeting may not have an immediate impact on the agency’s current stance on xenotransplantation, changes are reportedly afoot. The WSJ spoke to a “person familiar with the matter” at the end of June who asserts the FDA is planning to launch pig-organ transplantation trials in an effort ease the shortage of transplantable human organs (*angrily shakes fist at seatbelts*). There’s no word on when such trials would launch as they are being handled on a case-by-case basis, the source said.